“We are proud to launch ORGOVYX in Europe, as an addition to our specialty brand offerings,” said Binish Chudgar, Managing Director of Accord.
Global Pharma | 12/05/2022 | By Content editor
Kelonia Therapeutics is the newest biotech to hit the pharma scene after receiving $50 million in start-up money.
Global Pharma | 30/04/2022 | By Sudeep Soparkar
Phosplatin Therapeutics Inc., a clinical stage pharmaceutical company, announced the first patient has been treated in a phase 2 clinical trial of the company's lead therapeutic candidate, PT-112, in patients with recurrent thymic epithelial tumours (TETs), specifically thymoma and thymic carcinoma.
Global Pharma | 15/04/2022 | By Sudeep Soparkar
UK-based startup Kyttaro and Eli Lilly have announced a new licensing deal.
Global Pharma | 14/04/2022 | By Sudeep Soparkar
In its recent statement Lupin has said that it received approval from the US health regulator to market Efinaconazole topical solution, used to treat fungal toenail infections, in the American market
Global Pharma | 07/03/2022 | By Darshana
The Centre of Excellence in Sustainable Cooling and Cold-Chain will conduct state-of-the-art applied research in food and vaccine distribution, supporting the roll-out of affordable, energy resilient, low emission cold-chain systems in India
Global Pharma | 04/03/2022 | By Darshana
Covaxin (BBVI52), which has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is an investigational vaccine candidate product in the US
Global Pharma | 22/02/2022 | By Darshana
he Ascent merger offers access to an attractive client portfolio and adds substantially to PharmaLex?s global footprint, not only in the Japanese market but in other key markets throughout East and Southeast Asia. With deep roots in Asia, Ascent can act as a true partner in the region and, through the merger with PharmaLex
Global Pharma | 10/02/2022 | By Darshana
The government has removed restrictions on exports of syringes with immediate effect, according to a notification. Restrictions were imposed last year in the wake of the COVID-19 pandemic
Global Pharma | 04/02/2022 | By Darshana
Aurobindo Pharma and Unichem Laboratories are recalling different products in the US market, the world's largest market for medicines, due to manufacturing issues. As per the latest enforcement report issued by the US Food and Drug Administration (FDA), Aurobindo's US-based unit is recalling 7,296 containers of hypertension drug Carvedilol tablets
Global Pharma | 08/12/2021 | By Darshana